CoVICIS has a global approach coupling state-of-the-art virologic and immunologic platforms with large genomic surveillance studies and diverse cohorts in EU and SSA.

CoVICIS aims to contribute to the early identification of emerging VOC and addresses key unanswered questions regarding the susceptibility to infection with VOC, the risk posed by VOC in immunocompromised patients, and the modalities of infection and immune responses in children.